ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 164 filers reported holding ACORDA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $9,182,000 | -39.7% | 347,157 | -2.5% | 0.52% | -22.2% |
| Q4 2015 | $15,237,000 | +81.9% | 356,170 | +12.7% | 0.67% | +52.4% |
| Q3 2015 | $8,377,000 | -35.6% | 315,980 | -19.0% | 0.44% | -17.9% |
| Q2 2015 | $13,006,000 | -8.5% | 390,212 | -8.6% | 0.54% | -4.3% |
| Q1 2015 | $14,208,000 | -18.0% | 426,937 | +0.7% | 0.56% | -22.8% |
| Q4 2014 | $17,321,000 | -25.3% | 423,806 | -38.1% | 0.73% | -25.0% |
| Q3 2014 | $23,189,000 | +16.6% | 684,455 | +16.0% | 0.97% | +25.7% |
| Q2 2014 | $19,891,000 | +54.0% | 590,055 | +73.2% | 0.77% | +57.0% |
| Q1 2014 | $12,915,000 | – | 340,688 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
| Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
| SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
| HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
| DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
| EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
| Benin Management CORP | 11,714 | $11,000 | 0.01% |